Literature DB >> 21767686

Normative values for the hospital anxiety and depression scale (HADS) in the general German population.

Andreas Hinz1, Elmar Brähler.   

Abstract

OBJECTIVE: The aim of this study was to present normative values for the Hospital Anxiety and Depression Scale (HADS).
METHODS: A representative sample of the German general population (N=4410) was tested with the HADS.
RESULTS: Females are more anxious than males, and older subjects are more depressed than younger subjects. The mean scores for anxiety / depression are 4.4 / 4.8 (males) and 5.0 / 4.7 (females). Using the cut-off 8+, the percentages of elevated anxiety and depression in the total sample are 21 % and 23 %, respectively. Regression analyses proved a linear but not a curvilinear age trend of anxiety and depression. Percentile rank norms are given for anxiety, depression, and the HADS total score.
CONCLUSION: The regression coefficients allow the calculation of expected mean scores for each age and gender distribution of any sample of patients. HADS mean scores are better suited to describe the degree of anxiety and depression in patient samples compared to percentages of subjects with elevated values.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21767686     DOI: 10.1016/j.jpsychores.2011.01.005

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  108 in total

1.  [Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population].

Authors:  D Freier; M Englbrecht; V Höhne-Zimmer; J Detert; G-R Burmester
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

Review 2.  [Distinctive features of orofacial pain perception].

Authors:  B Steiger; D Ettlin
Journal:  Schmerz       Date:  2015-04       Impact factor: 1.107

3.  Changes in BMI and psychosocial functioning in partners of women who undergo gastric bypass surgery for obesity.

Authors:  Mikaela Willmer; Daniel Berglind; Anders Thorell; Magnus Sundbom; Joanna Uddén; Mustafa Raoof; Jakob Hedberg; Per Tynelius; Ata Ghaderi; Erik Näslund; Finn Rasmussen
Journal:  Obes Surg       Date:  2015-02       Impact factor: 4.129

4.  Two-year patient-reported outcomes following treatment of uveal melanoma.

Authors:  L Hope-Stone; S L Brown; H Heimann; B Damato; P Salmon
Journal:  Eye (Lond)       Date:  2016-09-02       Impact factor: 3.775

5.  Can a workplace leadership intervention reduce job insecurity and improve health? Results from a field study.

Authors:  Amira Barrech; Christian Seubert; Jürgen Glaser; Harald Gündel
Journal:  Int Arch Occup Environ Health       Date:  2018-03-22       Impact factor: 3.015

Review 6.  Anxiety symptoms in survivors of critical illness: a systematic review and meta-analysis.

Authors:  Sina Nikayin; Anahita Rabiee; Mohamed D Hashem; Minxuan Huang; O Joseph Bienvenu; Alison E Turnbull; Dale M Needham
Journal:  Gen Hosp Psychiatry       Date:  2016-08-28       Impact factor: 3.238

7.  Children and Employment - Resource or Stressors after Breast Cancer?

Authors:  K Ebenhan; K Leuteritz; Y Barthel; M E Beutel; K Papsdorf; G Weissflog; E Brähler
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-08       Impact factor: 2.915

8.  Psychological distress of cancer patients with children under 18 years and their partners-a longitudinal study of family relationships using dyadic data analysis.

Authors:  Heide Götze; Michael Friedrich; Elmar Brähler; Georg Romer; Anja Mehnert; Jochen Ernst
Journal:  Support Care Cancer       Date:  2016-09-13       Impact factor: 3.603

9.  Effect of Hatha Yoga on Anxiety: A Meta-Analysis.

Authors:  Stefan G Hofmann; Giovanbattista Andreoli; Joseph K Carpenter; Joshua Curtiss
Journal:  J Evid Based Med       Date:  2016-05-20

Review 10.  Diagnosis and Management of Pain in Parkinson's Disease: A New Approach.

Authors:  Veit Mylius; Jens Carsten Möller; Stephan Bohlhalter; Daniel Ciampi de Andrade; Santiago Perez Lloret
Journal:  Drugs Aging       Date:  2021-07-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.